July 5th Potcast sponsored by Lexaria Bioscience Corp. (CSE: $LXX.C) (OTC: $LXRP) a #Cannabis company with a new disruptive drug delivery platform: DehydraTECH
Pt. Roberts, WA; Delta, BC –July 5, 2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its “potcast’ site, www.potcasts.ca release today’s edition of its series, Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Today’s podcast overview/transcript:
Good afternoon and welcome to another Investorideas.com potcast ; looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.
Today’s potcast was sponsored by Kelowna based Lexaria Bioscience Corp trading on the CSE under symbol LXX and on the OTC as LXRP. Lexaria has developed a new disruptive drug delivery platform: DehydraTECH The Company’s patented technology changes the way Active Pharmaceutical Ingredients (“APIs”) enter the body orally:
1) Masks unwanted tastes – eliminates the need for sugar-filled edibles.
2) Reduces time of onset – effects are felt within 15-20 min vs. 60-120 min.
3) Avoids first-pass liver metabolism
4) Increases bio-absorption by 5-10X
The Company’s DehydraTECH™ technology is patent-protected for multiple APIs: Cannabidiol (NYSE:CBD), Tetrahydrocannabinol (NYSE:THC), Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, Nicotine and Fat soluble vitamins.
Learn more about Lexaria at www.lexariabioscience.com
Canopy Growth Corporation introduced its Latin American affiliate Canopy LATAM Corporation ("Canopy LATAM"), a wholly owned and controlled subsidiary of Canopy Growth Corporation. Through Canopy LATAM, the Company has acquired Spectrum Cannabis Colombia S.A.S. ("Spectrum Cannabis Colombia"), which previously operated as Colombian Cannabis S.A.S. ("Colombian Cannabis"), expanding the Company's focus on the emerging medical cannabis market of Latin America.
This announcement represents a leap forward in the Company's growth strategy for its industry leading Spectrum Cannabis brand. As a member of the Canopy Growth family, Canopy LATAM will focus on advancing medical cannabis and capturing market share across the region, home to more than 600 million people, as individual nations modernize their medical cannabis legislation.
Canopy Growth Corporation also announced that it has closed its previously announced transaction to acquire the remaining 33% stake of BC Tweed Joint Venture Inc. ("BC Tweed"). The consolidation of the two largest federally licensed cannabis facilities in the world into full Canopy Growth ownership cements the Company's commitment to shareholder value through scale production.
"Our BC Tweed operations have allowed us to pursue and finalize large recreational supply contracts across Canada," said Mark Zekulin, President and Co-CEO, Canopy Growth. "Construction and retrofitting work continues at both greenhouse sites to continue on an aggressive pace towards licensing all 3 million sq. ft. of production."
Finally, Canopy Growth Corporation also announced the completion of a major supply agreement with the Alberta Gaming, Liquor & Cannabis Commission ("AGLC") to supply the province with premium cannabis products in a variety of forms including whole-flower, oil, and Softgel capsules.
Under the terms of the agreement, the largest of its kind in Canada, Canopy Growth will supply Alberta with over 15,000 kilograms of cannabis products to support the first six months of the province's adult use recreational cannabis market set to open on October 17, 2018. Inventory will be replenished by the Company as requested and the AGLC reserves the right to extend the agreement for up to two additional years in 12-month increments. Should the need arise, Canopy Growth is prepared to go beyond the minimum supply commitment to ensure the AGLC has sufficient product to meet market demand.
Combining the Company's supply agreements with six provinces and one territory including New Brunswick, Newfoundland & Labrador, Prince Edward Island, Quebec, Yukon, recently announced Manitoba and now Alberta, Canopy Growth is committed to supply these markets on an annualized basis with up to 61,500 kilograms of cannabis products in the first year of legal sales with varying incremental multi-year obligations by province. Supply agreements are supported by a national production platform which includes a state-of-the-art indoor production facility located just outside Edmonton, Alberta. Initially announced in June 2017, the production site ensures that Albertans are accessing Tweed and other Canopy Growth-affiliated products from a company proudly investing in the province.
Aurora Cannabis Inc. announced that it has also entered into an agreement with the Alberta Gaming, Liquor & Cannabis Commission ("AGLC") to supply high-quality cannabis products for the adult consumer use market in the province. Consequently, Aurora will initially allocate up to 25,000 kg of product for the first 6 months of sales to this market.
Aurora's three facilities in Alberta - Aurora Sky, Mountain, and Sun - with a combined funded production capacity of more than 250,000 kg per year, uniquely position Aurora to provide a reliable, high-quality supply of cannabis to the Province. Through this agreement, Aurora, which is the leader in the medical cannabis market in Alberta, will play an important role in ensuring sufficient product is available to the adult consumer market in the province.
Aphria Inc. today announced that it has signed a Supply Agreement with the Alberta Gaming, Liquor & Cannabis Commission as well, to provide a portfolio of high-quality cannabis and cannabis-derivative products for sale in Alberta's adult-use market.
Under the terms of the Agreement, the AGLC has placed an opening order of 870 kg to be supplied from across the full portfolio of Aphria's adult-use brands and products, including dried flower, pre-rolls and cannabis oils. Once additional product categories, such as vapes and edibles, are authorized under the Cannabis Act, it is anticipated that they will also be made for sale throughout the province, further enhancing the Company's assortment of offerings in this market.
Aphria Inc. also announced that it has successfully completed the divestiture of the Company's ownership interest in Copperstate Farms, LLC and Copperstate Farms Investors, LLC previously announced on February 2, 2018. Aphria's original investment was approximately $11.1 million ($8.2 million USD). Aphria received $20 million as part of the divestiture, realizing a gain of approximately $8.8 million on the sale.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
Lexaria Bioscience Corp. has developed and out-licenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the USA and in Australia for utilization of its DehydraTECHTM delivery technology. Lexaria's technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. www.lexariabioscience.com
Subscribe to the new cannabis podcast series:
To hear more Investorideas.com podcasts visit: Investorideas.com Podcasts with CEO's and experts in bitcoin, blockchain, biotech, cannabis, mining, tech now on iTunes, Google Play Music, iHeart.com, SoundCloud.
Investorideas.com podcasts are also available on iTunes, Google Play Music, Stitcher and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Ideas
Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, company profiles, interviews and more in leading sectors.
Investorideas.com cannabis/marijuana and hemp content now includes Cannabis Stock News- Investing in Cannabis and Hemp Stocks on Blogger.com: the Investorideas.com news and stock directory pages, a cannabis investor group on Linkedin.com , the 420 Cannabis Investor ideas www.420cannabisinvestorideas.com, and the new AI site Global Cannabis Investing at www.Globalcannabisinvesting.com
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: InvestorIdeas - Disclaimer, full disclosure, compensation disclosure Disclosure Lexaria Bioscience Corp. ( CSE: LXX) (OTC: LXRP) is a media sponsor of the podcast starting July 5 2018 more info Investorideas.com - Client Specifics
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: BCSC releases rule for U.S. OTC issuers. Global investors must adhere to regulations of each country.
Follow us on Social Media
Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory
Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing
Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.
Additional disclosure: Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: www.investorideas.com/... Disclosure Lexaria Bioscience Corp. ( CSE: LXX) (OTC: LXRP) is a media sponsor of the podcast starting July 5 2018 more info www.investorideas.com/...
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: www.bcsc.bc.ca/... Global investors must adhere to regulations of each country.